Clinical Trial Update: Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study

View source ↗

Summary

This completed population-based study investigates whether fingolimod use in people with multiple sclerosis is associated with skin cancer risk, including melan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Melanoma
• Multiple Sclerosis
• Skin Cancer
• Squamous Cell Carcinoma

Drugs mentioned

• GILENYA (FINGOLIMOD HCL)

Snippet

Sponsor: University of British Columbia | Conditions: Multiple Sclerosis, Skin Cancer | Status: COMPLETED